FEMSelect

Surgical Devices · Newark, DE · Founded 2012 · Privately Held (backing)

Developer of medical devices designed to treat pelvic organ prolapse disease in women. FEMSelect is based in Newark, DE and was founded in 2012. It was valued at $17 million at its later-stage round in Sep 2022, the last priced event on record. It has raised $12.2 million across 1 recorded round; the latest was an accelerator round in Jan 2018.

PMV mark · valuation
$17.0M
Oct 2026
Priced at
its later-stage round
Sep 2022
Total raised
$12.2M
Last round
Accelerator/Incubator
Jan 2018
Cap table — not yet on record

FEMSelect's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of FEMSelect with a free account
  • ·The complete investor list: 21 names
  • ·Watch FEMSelect: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about FEMSelect

Where does FEMSelect's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across FEMSelect's 1 recorded funding rounds.